Donaldson Capital Management, LLC Amgen Inc Transaction History

Donaldson Capital Management, LLC

$2.59 Billion
Q3 2024

A detailed history of Donaldson Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Donaldson Capital Management, LLC holds 9,496 shares of AMGN stock, worth $2.8 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

9,496

Previous 10,291 7.73%

Holding current value

$2.8 Million

Previous $3.22 Million 4.85%

% of portfolio

0.12%

Previous 0.13%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$309.38 - $337.38 $245,957 - $268,217	-795 Reduced 7.73%	9,496 $3.06 Million
Q2 2024 Jul 31, 2024	BUY	$262.75 - $319.31 $262 - $319	1 Added 0.01%	10,291 $3.22 Million
Q1 2024 Apr 22, 2024	SELL	$268.87 - $324.56 $206,223 - $248,937	-767 Reduced 6.94%	10,290 $2.93 Million
Q4 2023 Jan 30, 2024	SELL	$255.7 - $288.46 $1.19 Million - $1.35 Million	-4,670 Reduced 29.69%	11,057 $3.18 Million
Q3 2023 Oct 11, 2023	SELL	$218.65 - $271.46 $60,347 - $74,922	-276 Reduced 1.72%	15,727 $4.23 Million
Q2 2023 Jul 17, 2023	SELL	$214.27 - $253.37 $82,922 - $98,054	-387 Reduced 2.36%	16,003 $3.55 Million
Q1 2023 Apr 13, 2023	SELL	$225.79 - $275.2 $44,932 - $54,764	-199 Reduced 1.2%	16,390 $3.96 Million
Q4 2022 Feb 08, 2023	SELL	$229.03 - $291.01 $67,563 - $85,847	-295 Reduced 1.75%	16,589 $4.36 Million
Q3 2022 Oct 13, 2022	SELL	$224.46 - $253.15 $26,935 - $30,378	-120 Reduced 0.71%	16,884 $3.81 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $19,610 - $21,822	-85 Reduced 0.5%	17,004 $4.14 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $90,339 - $99,938	-412 Reduced 2.35%	17,089 $4.13 Million
Q4 2021 Jan 21, 2022	SELL	$198.88 - $227.6 $53,100 - $60,769	-267 Reduced 1.5%	17,501 $3.94 Million
Q3 2021 Nov 04, 2021	SELL	$212.27 - $248.7 $143,919 - $168,618	-678 Reduced 3.68%	17,768 $3.78 Million
Q2 2021 Jul 28, 2021	SELL	$233.58 - $259.14 $233,346 - $258,880	-999 Reduced 5.14%	18,446 $4.5 Million
Q1 2021 May 05, 2021	BUY	$221.91 - $258.6 $44,160 - $51,461	199 Added 1.03%	19,445 $4.84 Million
Q4 2020 Jan 11, 2021	SELL	$216.38 - $257.67 $73,136 - $87,092	-338 Reduced 1.73%	19,246 $4.43 Million
Q3 2020 Nov 02, 2020	SELL	$234.65 - $260.95 $7,743 - $8,611	-33 Reduced 0.17%	19,584 $4.98 Million
Q2 2020 Jul 27, 2020	SELL	$197.81 - $242.74 $78,728 - $96,610	-398 Reduced 1.99%	19,617 $4.63 Million
Q1 2020 Apr 16, 2020	BUY	$182.24 - $241.7 $405,301 - $537,540	2,224 Added 12.5%	20,015 $4.06 Million
Q4 2019 Jan 14, 2020	SELL	$189.21 - $243.2 $58,465 - $75,148	-309 Reduced 1.71%	17,791 $4.29 Million
Q3 2019 Nov 04, 2019	SELL	$174.11 - $208.62 $26,638 - $31,918	-153 Reduced 0.84%	18,100 $3.5 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $27.4 Million - $32.1 Million	-164,462 Reduced 90.01%	18,253 $3.36 Million
Q1 2019 Apr 01, 2019	BUY	$180.87 - $203.88 $1.08 Million - $1.22 Million	5,964 Added 3.37%	182,715 $34.7 Million
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $742,144 - $866,320	4,160 Added 2.41%	176,751 $34.4 Million
Q3 2018 Nov 06, 2018	BUY	$185.29 - $208.89 $1.02 Million - $1.15 Million	5,485 Added 3.28%	172,591 $35.8 Million
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $418,279 - $469,818	-2,519 Reduced 1.49%	167,106 $30.8 Million
Q1 2018 Apr 30, 2018	BUY	$169.43 - $198.0 $686,869 - $802,692	4,054 Added 2.45%	169,625 $28.9 Million
Q4 2017 Jan 30, 2018	BUY	$168.79 - $188.59 $27.2 Million - $30.4 Million	161,200 Added 3687.94%	165,571 $28.8 Million
Q4 2017 Jan 26, 2018	SELL	$168.79 - $188.59 $27.4 Million - $30.6 Million	-162,164 Reduced 97.38%	4,371 $760,000
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $27.9 Million - $31.8 Million	166,535	166,535 $31.1 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Donaldson Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donaldson Capital Management, LLC with notifications on news.

Account

Donaldson Capital Management, LLC Amgen Inc Transaction History